首頁 > 市場調查報告書 > 醫療設備

生技設備

多重檢測市場規模、佔有率和成長分析（按產品類型、技術、應用、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1897576

多重檢測市場規模、佔有率和成長分析（按產品類型、技術、應用、最終用戶和地區分類）－2026-2033年產業預測

Multiplex Assay Market Size, Share, and Growth Analysis, By Product Type (Consumables, Instruments), By Type (Protein Multiplex Assays, Nucleic Acid Multiplex Assays), By Technology, By Application, By End-User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，多重檢測市場規模將達到 40.5 億美元，到 2025 年將達到 44.3 億美元，到 2033 年將達到 91.7 億美元，預測期（2026-2033 年）的複合年成長率為 9.5%。

由於慢性病和感染疾病率的上升、多重檢測方法相較於傳統方法的優勢以及伴隨診斷作用的日益增強，全球多重檢測市場正經歷顯著成長。新型伴隨診斷的核准將進一步提升市場潛力，尤其是在識別能夠從標靶治療中獲益的患者方面。癌症等疾病的早期診斷至關重要，因為它可以顯著提高生存率和患者的生活品質，因此在醫學界日益受到重視。此外，對自動化系統和高通量檢測的需求不斷成長，以及生物標記檢驗的進步，都為市場擴張創造了機會。同時，多重檢測能夠分析多種生物標記物，從而簡化了各個疾病領域創新診斷方法的開發。

多重檢測市場促進因素

人們對個人化醫療日益成長的興趣是多重檢測市場的主要驅動力。這些先進的檢測方法能夠同時評估多種生物標記物，從而提高根據患者個體反應和生物學特徵進行分類的能力。這有助於制定更個人化的治療策略，改善患者預後並最佳化治療效果。隨著醫療保健不斷朝向個人化方向發展，多重檢測將在提供精準醫療解決方案方面發揮越來越重要的作用，最終改變患者照護，並擴大這些創新診斷工具的整體市場。

限制多重檢測市場發展的因素

全球多重檢測市場的主要限制因素之一是檢測開發和部署的複雜性和高成本。多重檢測的複雜性需要先進的技術和專用設備，這可能會阻礙小規模實驗室和機構採用這些先進的檢測方法。此外，操作多重檢測系統需要大量的培訓和技術專長，這進一步加劇了市場複雜性。這些因素可能會限制其普及性並增加營運成本，最終阻礙潛在用戶的採用率並減緩市場成長。此外，與檢驗和核准流程相關的監管障礙也可能帶來額外的挑戰。

多重檢測市場趨勢

多重檢測市場正經歷顯著的成長趨勢，這主要得益於多重免疫檢測技術的日益普及。該技術能夠同時檢測單一檢體中的多種蛋白質，從而顯著提升藥物研發、診斷檢測和生物標記鑑定流程的效率，滿足了醫療保健和研究領域對快速、全面分析日益成長的需求。此外，檢測技術的進步和自動化技術的整合也進一步推動了市場成長。隨著研究人員和臨床醫生對具成本效益、高通量解決方案的需求不斷成長，預計對多重檢測的需求將持續攀升，鞏固其作為現代分析方法中不可或缺的工具的地位。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Lonza Group（Switzerland）
DiaSorin（Italy）
WuXi Biologics（China）
Seegene（South Korea）
Ayoxxa Biosystems（Germany）
Thermo Fisher Scientific（United States）
Bio-Rad Laboratories（United States）
Luminex Corporation（United States）
QIAGEN（Germany）
Illumina（United States）
Agilent Technologies（United States）
PerkinElmer（United States）
Merck KGaA（Germany）
Becton, Dickinson and Company（United States）
Roche Diagnostics（Switzerland）
Siemens Healthineers（Germany）
Danaher Corporation（United States）
Abbott Laboratories（United States）
Meso Scale Diagnostics（United States）
Quanterix Corporation（United States）

結論與建議

簡介目錄

Product Code: SQMIG35H2180

Multiplex Assay Market size was valued at USD 4.05 Billion in 2024 and is poised to grow from USD 4.43 Billion in 2025 to USD 9.17 Billion by 2033, growing at a CAGR of 9.5% during the forecast period (2026-2033).

The global multiplex assay market is experiencing significant growth driven by the increasing prevalence of chronic and infectious diseases, the advantages of multiplex assays over traditional methods, and their expanding role in companion diagnostics. The approval of new companion diagnostics is expected to further enhance market potential, particularly in identifying patients who would benefit from targeted therapies. Early diagnosis of diseases like cancer is crucial, as it can significantly improve survival rates and patient quality of life, leading to heightened awareness in the healthcare sector. Moreover, the rising demand for automated systems and high-throughput assays, along with the validation of biomarkers, amplifies opportunities for market expansion. Furthermore, multiplex assays facilitate extensive biomarker analysis, streamlining the development of innovative diagnostics in various disease areas.

Top-down and bottom-up approaches were used to estimate and validate the size of the Multiplex Assay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Multiplex Assay Market Segments Analysis

Global Multiplex Assay Market is segmented by Product Type, Type, Technology, Application, End-User and region. Based on Product Type, the market is segmented into Consumables, Instruments and Software. Based on Type, the market is segmented into Protein Multiplex Assays, Nucleic Acid Multiplex Assays and Cell-based Multiplex Assays. Based on Technology, the market is segmented into Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-time PCR and Others. Based on Application, the market is segmented into Research & Development and Clinical Diagnostics. Based on End-User, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Multiplex Assay Market

The increasing interest in personalized medicine is significantly propelling the multiplex assay market. These advanced assays facilitate the concurrent assessment of multiple biomarkers, which enhances the ability to classify patients based on their individual responses and biological characteristics. Consequently, this capability leads to more tailored treatment strategies, improving patient outcomes and optimizing therapeutic efficacy. As healthcare continues to evolve towards more individualized approaches, the role of multiplex assays becomes increasingly vital in delivering precision medicine solutions, ultimately transforming patient care and boosting the overall market for these innovative diagnostic tools.

Restraints in the Multiplex Assay Market

One key market restraint for the global multiplex assay market is the complexity and high cost associated with assay development and implementation. The intricate nature of multiplex assays, which require sophisticated technologies and specialized equipment, can deter smaller laboratories or facilities from adopting these advanced testing methods. Additionally, the need for extensive training and technical expertise to operate multiplex assay systems further complicates the market landscape. These factors can limit accessibility and increase operational expenses, ultimately hindering adoption rates among potential users and slowing market growth. Furthermore, regulatory hurdles related to validation and approval processes can introduce additional challenges.

Market Trends of the Multiplex Assay Market

The multiplex assay market is witnessing a notable trend driven by the growing adoption of multiplex immunoassays, which enable the simultaneous measurement of multiple proteins from a single sample. This capability significantly enhances efficiency in drug discovery, diagnostic testing, and biomarker identification processes, catering to the rising need for rapid and comprehensive analysis in healthcare and research. Additionally, advancements in assay technologies and the integration of automation are further propelling market growth. As researchers and clinicians increasingly seek cost-effective, high-throughput solutions, the demand for multiplex assays is expected to expand, solidifying their role as essential tools in modern analytical practices.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Multiplex Assay Market Size by Product Type & CAGR (2026-2033)

Market Overview
Consumables
Instruments
Software

Global Multiplex Assay Market Size by Type & CAGR (2026-2033)

Market Overview
Protein Multiplex Assays
- Planar Protein Assays
- Bead-based Protein Assays
- Others
Nucleic Acid Multiplex Assays
- Planar Nucleic Acid Assays
- Bead-based Nucleic Acid Assays
- Others
Cell-based Multiplex Assays

Global Multiplex Assay Market Size by Technology & CAGR (2026-2033)

Market Overview
Flow Cytometry
Fluorescence Detection
Luminescence
Multiplex Real-time PCR
Others

Global Multiplex Assay Market Size by Application & CAGR (2026-2033)

Market Overview
Research & Development
- Drug Discovery & Development
- Biomarker Discovery & Validation
Clinical Diagnostics
- Infectious Diseases
- Cancer
- Cardiovascular Diseases
- Autoimmune Diseases
- Nervous System Disorders
- Metabolism & Endocrinology Disorders
- Other Diseases

Global Multiplex Assay Market Size by End-User & CAGR (2026-2033)

Market Overview
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Reference Laboratories
Others

Global Multiplex Assay Market Size & CAGR (2026-2033)

North America (Product Type, Type, Technology, Application, End-User)
- US
- Canada
Europe (Product Type, Type, Technology, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Type, Technology, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Type, Technology, Application, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Type, Technology, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Lonza Group (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi Biologics (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seegene (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ayoxxa Biosystems (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meso Scale Diagnostics (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quanterix Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments